CLINICAL CANCER RESEARCH

简称 CLIN CANCER RES ·UNITED STATES ·出版周期 Semimonthly ·年均收录 613 篇

10.2

最新影响因子

3.70%

自引率

约30%

投稿难度

平均2.1月

审稿周期

期刊简介

CLINICAL CANCER RESEARCH是一本专注于临床癌症研究的国际期刊，ISSN号为1078-0432，由美国癌症研究协会（AACR）出版，每月出版两次，出版地为美国费城。该期刊为非开放获取（非OA）期刊，被SCI收录，2022年影响因子为11.5，在中科院分区中通常位于医学大类1区或2区。其发文特点集中于转化医学和临床癌症研究，涵盖肿瘤生物学、靶向治疗、免疫治疗、临床试验及癌症预防等领域，旨在推动基础研究成果向临床应用的转化。杂志以高质量和严格的同行评审著称，但投稿竞争激烈，拒稿率较高，对研究的创新性和临床相关性要求严格，适合发表具有重要临床意义的前沿研究。

影响因子趋势

近期发表

Clinical, Genomic, and Spatial Transcriptomic Features of Pancreatic Adenosquamous Carcinoma Support Subtype-Specific Therapeutic Strategies 2026-08-14

Phase I Trial of IL13Rα2-Targeted CAR T-cell Therapy for Recurrent Malignant Glioma: Clinical Results and Pharmacokinetics 2026-08-04

DNMT3B Plays Antagonistic Roles with SMARCB1 and Is a Targetable Vulnerability in Rhabdoid Tumors 2026-08-10

Expression of Concern: Pancreatic Tumor Suppression by Benzyl Isothiocyanate Is Associated with Inhibition of PI3K/AKT/FOXO Pathway 2026-09-01

Targetable S100–RAGE Signaling Mediates Intrinsic Trastuzumab Deruxtecan Resistance in Metastatic Breast Cancer 2026-07-17

FDA Approval Summary: Erdafitinib for FGFR3 -Altered Locally Advanced or Metastatic Urothelial Carcinoma 2026-08-12

Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases 2026-08-28

Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study 2026-07-30

Multicenter Phase I Study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388) 2026-07-28

Weight Loss Responses to Pharmacotherapy in Breast Cancer Survivors: Results from the Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study 2026-08-04